A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

BACKGROUND: Concurrent chemoradiotherapy is a standard modality for locally advanced esophageal squamous cell carcinoma (ESCC) patients. Cisplatin combined with 5-fluorouracil continuous infusion (PF) remains the standard concurrent chemotherapy regimen. However, radiotherapy concurrent with PF show...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yun, Zhu, Zhengfei, Zhao, Weixin, Li, Ling, Ye, Jinjun, Wu, Chaoyang, Tang, Huarong, Lin, Qin, Li, Jiancheng, Xia, Yi, Li, Yunhai, Zhou, Jialiang, Zhao, Kuaile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828310/
https://www.ncbi.nlm.nih.gov/pubmed/29482649
http://dx.doi.org/10.1186/s13014-018-0979-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828310/
https://www.ncbi.nlm.nih.gov/pubmed/29482649
http://dx.doi.org/10.1186/s13014-018-0979-0

Ejemplares similares